Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Netscientific Plc (NSCI.LN)

Netscientific Plc (NSCI.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Netscientific Plc 20 Saint Andrew Street, Level 8 Holborn Circus London EC4A 3AG GBR

P: 203-514-1800

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding, and commercializing technologies and companies that have the potential to treat chronic diseases and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection, and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

Key Statistics

Overview:

Market Capitalization, $K 13,170
Shares Outstanding, K 23,946
% of Insider Shareholders 19.25%
% of Institutional Shareholders 59.03%

Financials:

Annual Sales, $ 1,445 K
Annual Net Income, $ -2,643 K

Growth:

1-Year Return -11.57%
3-Year Return -56.85%
5-Year Return -33.13%
5-Year Revenue Growth 42.61%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.11
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/25/20

NSCI.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -12.10%
Return-on-Assets % -10.28%
Profit Margin % -182.91%
Debt/Equity 0.10
Price/Sales 8.95
Price/Book 0.74
Book Value/Share 0.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar